| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/02/2009 | EP2095825A1 Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method |
| 09/02/2009 | EP2095823A1 GM-CSF for treating demyelination |
| 09/02/2009 | EP2095818A1 Use of LHRH antagonists at non-castrating doses |
| 09/02/2009 | EP2094672A2 Arylsulfonamide compounds |
| 09/02/2009 | EP2094288A2 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| 09/02/2009 | EP1478233A4 Method for administering glp-1 molecules |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | EP1457498B9 Novel peptide having angiotensin convertase inhibitory effect |
| 09/02/2009 | EP1432718B1 Phosphor containing compounds with antithrombitic activity |
| 09/02/2009 | EP1423115B9 Antiangiogenic activity of nitrogen substituted thalidomide analogs |
| 09/02/2009 | EP1364027B1 Zinc finger binding domains for nucleotide sequence ann |
| 09/02/2009 | EP1300395B1 4-substituted piperidine compound |
| 09/02/2009 | EP1282443B1 Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy |
| 09/02/2009 | EP1087991B1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 09/02/2009 | EP0892643B2 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 09/02/2009 | CN101519394A 3-aryl-coumarin derivatives and preparation method and application thereof |
| 09/02/2009 | CN101519386A Large conductance calcium-activated K channel opener |
| 09/02/2009 | CN101519385A Small molecule compound being capable of promoting proliferation of stem cells and function thereof |
| 09/02/2009 | CN101519372A Benzo [e] isoindazole-1,3 diketone compound used as GSK inhibiting agent and preparation method thereof |
| 09/02/2009 | CN101519368A Small molecule entry inhibitors |
| 09/02/2009 | CN101518653A Methods of treatment using anti-erbb antibody-maytansinoid conjugates |
| 09/02/2009 | CN101518648A Soluble receptor BR43x2 and methods of using |
| 09/02/2009 | CN100535013C Selective targeting of tumor vasculature using antibody molecules |
| 09/02/2009 | CN100534991C Heterocyclic inhibitors of ERK 2 and uses thereof |
| 09/02/2009 | CN100534523C Health food having delaying senility and beautifying function and preparation method thereof |
| 09/02/2009 | CN100534485C Preparation prepared by biological chitin and traditional Chinese medicine for postponing senescence |
| 09/01/2009 | US7582778 Podophyllotoxin |
| 09/01/2009 | US7582734 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling |
| 09/01/2009 | US7582730 an iron-regulated protein found in Neisseria gonorrhoeae or Neisseria meningitidis outer membranes; immunizing a host against gonococcal and meningococcal diseases, such as gonorrhea, meningitis |
| 09/01/2009 | US7582665 Heterocyclic sulfur compounds and/or prodrugs administered for prophylaxis of thrombocytopenia, anemia or blood disorders |
| 09/01/2009 | US7582662 Body weight gain inhibitor |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582654 Antiarrhythmia agents, treating gastrointensinal disorder, gastroesophageal reflux, chronic obstructive pulmonary disease, diabetes;N-cotnaining heterocyclic compound with carbamate or amide groups and indazole ring |
| 09/01/2009 | US7582651 Pyrrolopyridine derivative and use thereof |
| 09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2009 | US7582603 Treatment of gastrointestinal inflammation by administering a peptide antagonist of tight junction opening that binds to the zonula occludens receptor, yet does not physiologically modulate the opening of mammalian tight junctions; celiac disease, inflammatory bowel disease |
| 09/01/2009 | US7582476 For diagnosis and treatment of estrogenic disorder of mutant ER alpha |
| 09/01/2009 | US7582440 Imaging, diagnosis and treatment of disease |
| 09/01/2009 | US7582439 Detecting the presence/absence of a complex of a Bim molecule (a novel member of the Bcl-2 family) and an antibody specific for a specific amino acid sequence;modulating physiological cell death or survival and/or modulating cell cycle entry; antiapoptosis; anticarcinogenic agents; autoimmune diseases |
| 09/01/2009 | US7582317 Food supplements comprising, as a health component, sargahydroquinoic acid or derivative thereof |
| 09/01/2009 | US7582289 administering to proliferating cells in a mammal having a Ras-activated pathway a viruse selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus virus under conditions which result in lysis of neoplasmic cell |
| 09/01/2009 | CA2506491C Novel derivatives of pyrrolidines and thiazolidines, process for preparing them and pharmaceutical compositions containing them |
| 09/01/2009 | CA2467378C Cereal beta glucan compositions, methods of preparation and uses thereof |
| 09/01/2009 | CA2452432C Active ingredient combination for the pharmacological therapy of nicotine dependence |
| 09/01/2009 | CA2432428C Quinazoline derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 09/01/2009 | CA2393344C Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 09/01/2009 | CA2389411C Use of egfr tyrosine kinase inhibitor for preventing breast cancer |
| 09/01/2009 | CA2385867C Sustained release form comprising alpha-lipoic acid or derivatives thereof |
| 09/01/2009 | CA2376691C Antipsychotic cyclic n-aralkylamines |
| 09/01/2009 | CA2308216C Use of non-immunosuppressive compounds for promoting nerve regeneration |
| 09/01/2009 | CA2274469C Serum-derived factor inducing cell differentiation and medical uses thereof |
| 09/01/2009 | CA2210812C T-cell affecting peptides |
| 08/27/2009 | WO2009104988A1 Pharmacological adjuvants based on coordination compounds of d-metals |
| 08/27/2009 | WO2009104807A1 Composition for modulating stem cell growth with prostaglandins |
| 08/27/2009 | WO2009104794A1 Method for producing founder animal for reproducing animals having lethal phenotype caused by gene modification |
| 08/27/2009 | WO2009104739A1 Solid preparation for oral administration |
| 08/27/2009 | WO2009104729A1 Amide derivative and pharmaceutical composition containing the same |
| 08/27/2009 | WO2009104388A1 Prophylactic/therapeutic agent for collagenosis |
| 08/27/2009 | WO2009104248A1 Adrenomedullin production enhancer |
| 08/27/2009 | WO2009103754A2 Novel use of 3,3'-diindolylmethane |
| 08/27/2009 | WO2009103218A1 Ethylidene hydrazine carboxamide derivatives, preparation process and pharmaceutical use thereof |
| 08/27/2009 | WO2009064195A3 Reduced sexual maturation in fish |
| 08/27/2009 | WO2009047303A3 Metabotropic glutamate receptor modulators for the treatment of pervasive developmental disorder |
| 08/27/2009 | WO2008121348A8 Peripheral opioid receptor antagonists and uses thereof |
| 08/27/2009 | US20090217392 Anti- integrin antibodies, compositions, methods and uses |
| 08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
| 08/27/2009 | US20090215890 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 08/27/2009 | US20090215880 Composition and Method for IN VIVO and IN VITRO Attenuation of Gene Expression Using Double Stranded RNA |
| 08/27/2009 | US20090215872 Methods for Controlling Stem Cell Differentiation |
| 08/27/2009 | US20090215856 Methods for monitoring IL-18 |
| 08/27/2009 | US20090215800 Enzyme and Receptor Modulation |
| 08/27/2009 | US20090215795 Cyclic amidine derivatives |
| 08/27/2009 | US20090215770 Substituted Quinazoline Derivatives as Inhibitors of Aurora Kinases |
| 08/27/2009 | US20090215749 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor |
| 08/27/2009 | US20090215747 Heterocyclic compounds as inhibitors of beta-lactamases |
| 08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 08/27/2009 | US20090215691 NOGO Receptor Antagonists |
| 08/27/2009 | US20090215688 GLP-I Agonist And Cardiovascular Complications |
| 08/27/2009 | US20090215680 Inhibitor peptides |
| 08/27/2009 | US20090215668 Methods of making and uses of compositions that modulate intronic region-encoded protein function |
| 08/27/2009 | US20090215009 Medical material, artificial tooth root, and method of producing medical material |
| 08/27/2009 | US20090214667 Medical technical product, method for producing the same and providing the same for surgery |
| 08/27/2009 | US20090214666 Chitin microparticles and their medical uses |
| 08/27/2009 | US20090214644 Tranexamic acid formulations with reduced adverse effects |
| 08/27/2009 | US20090214625 Drug delivery patch |
| 08/27/2009 | US20090214614 Method for Cell Implantation |
| 08/27/2009 | US20090214605 Hydrophilic Core Polymeric Micelles for the Delivery of Water-Soluble Compounds |
| 08/27/2009 | US20090214542 Novel therapeutic targets in cancer |
| 08/27/2009 | US20090214505 For treating an excess of a substrate for a hyaluronidase, such as reducing scar tissue |
| 08/27/2009 | US20090214492 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 08/27/2009 | US20090214474 Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
| 08/27/2009 | CA2715771A1 Adrenomedullin production enhancer |
| 08/27/2009 | CA2715760A1 Solid preparation for oral administration |
| 08/27/2009 | CA2715486A1 Composition for modulating stem cell growth with prostaglandins |
| 08/27/2009 | CA2713412A1 Amide derivative and pharmaceutical composition containing the same |
| 08/26/2009 | EP2093292A2 Inhibition of specific histone deacetylase isoforms |
| 08/26/2009 | EP2093214A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 08/26/2009 | EP2092936A2 Tamper-resistant oral opioid agonist formulations |
| 08/26/2009 | EP1561759B9 Cell death-inducing agent |
| 08/26/2009 | EP1537875B1 C-terminal globular domain of adiponectin for use in the treatment of arteriosclerosis |